The role of TP53 gene analysis in EUS-guided FNA specimens for differential diagnosis of pancreatic ductal adenocarcinoma

The role of TP53 gene analysis in EUS-guided FNA specimens for differential diagnosis of pancreatic ductal adenocarcinoma - TP53 gene analysis in pancreatic ductal adenocarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020283

Enrollment

160

Registered

2015-12-20

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic solid mass

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent EUS-guided FNA of pancreatic masses.

Exclusion criteria

Exclusion criteria: Case whom no consent is obtained.

Design outcomes

Primary

Measure	Time frame
Improvement of the diagnostic accuracy by TP53 gene analysis in EUS-guided FNA specimens from pancreatic solid masses	—

Secondary

Measure	Time frame
Development of predictive factors in therapeutics	—

Countries

Japan,North America

Contacts

Public ContactYasuki Hori

Nagoya City University Graduate School of Medical Sciences Department of Gastroenterology and Metabolism

yhori@med.nagoya-cu.ac.jp+81-52-853-8211

Outcome results